Search Results for "Relenza"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Relenza. Results 1 to 4 of 4 total matches.
See also: zanamivir
Comparison Table: Antiviral Drugs for Seasonal Influenza for 2025-2026 (online only)
The Medical Letter on Drugs and Therapeutics • Oct 27, 2025 (Issue 1740)
) ▪ Not FDA-approved for chemoprophylaxis 950.00
Zanamivir – Relenza (GSK)
5 mg blisters of powder ...
View the Comparison Table: Antiviral Drugs for Seasonal Influenza for 2025-2026
Med Lett Drugs Ther. 2025 Oct 27;67(1740):e178-80 doi:10.58347/tml.2025.1740d | Show Introduction Hide Introduction
Drugs Past Their Expiration Date
The Medical Letter on Drugs and Therapeutics • Jan 05, 2026 (Issue 1745)
to use the antiviral drugs Tamiflu
(oseltamivir; 75-mg capsules) and Relenza (zanamivir
inhalation ...
Healthcare providers are often asked if drugs can
be used past their expiration date. Because of legal
restrictions and liability concerns, manufacturers do
not sanction such use and usually do not comment
on the safety or effectiveness of their products beyond the date on the label. Since our last article on this
subject, more data have become available.
Med Lett Drugs Ther. 2026 Jan 5;68(1745):5-7 doi:10.58347/tml.2026.1745c | Show Introduction Hide Introduction
Antiviral Drugs for Seasonal Influenza for 2025-2026
The Medical Letter on Drugs and Therapeutics • Oct 27, 2025 (Issue 1740)
of severe influenza10
Not FDA-approved for chemoprophylaxis
950.00
Zanamivir – Relenza (GSK)
5 mg ...
Influenza is generally a self-limited illness, but complications
including pneumonia, respiratory failure, and
death can occur, especially in persons at increased
risk (see Table 1).
Med Lett Drugs Ther. 2025 Oct 27;67(1740):169-74 doi:10.58347/tml.2025.1740a | Show Introduction Hide Introduction
Influenza Vaccines for 2025-2026
The Medical Letter on Drugs and Therapeutics • Sep 29, 2025 (Issue 1738)
, and generics) or zanamivir (Relenza) within
48 hours before, peramivir (Rapivab) within 5 days
before ...
Annual vaccination against influenza A and B viruses
is recommended in the US for everyone ≥6 months
old without a contraindication. Influenza vaccines
available in the US for the 2025-2026 season are listed
in Table 2.
Med Lett Drugs Ther. 2025 Sep 29;67(1738):153-8 doi:10.58347/tml.2025.1738a | Show Introduction Hide Introduction
